Global Biosimilars Market Size

Global Biosimilars Market Outlook, Opportunities And Strategies – Includes Biosimilars Vs Generic

Learn about the global biosimilars market through The Business Research Company, which provides information on biosimilars market size, biosimilars market drivers and restraints, biosimilars market players, the COVID-19 impact on the biosimilars market, and more.


The biosimilars market size is expected to grow from $11.41 billion in 2021 to $25.98 billion in 2026 at a rate of 17.3%. The market is then expected to grow at a CAGR of 18.0% from 2026 and reach $59.55 billion in 2031.


High penetration of the biologics is expected to be a driver of market growth during this period.


Request A Sample For The Global Biosimilars Market Report:


Global Biosimilars Market Trends
Global Biosimilars Market Report


The biosimilars market consists of sales of biosimilars and related services that are used to treat chronic diseases such as diabetes, arthritis, and cancer. Biosimilars are pharmaceuticals that are proteins and are expressed in mammalian cell lines using cell lines and have been shown to offer no clinical difference compared to approved biologics. Biosimilars are made once the patent of the original biologic has expired.


Global Biosimilars Market Segments Include:
By Type: Human Growth Hormone, Erythropoietin, Monoclonal Antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor, Others

By Application: Oncology, Chronic and Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, Others

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, Western Europe was the largest region in the global biosimilars market, accounting for 66% of the total in 2021.


The biosimilars market is witnessing robust research and development activities. These research and development activities have led to increasing success rates in clinical trials. Research and development is being carried out by market leaders in the biosimilars market as they continuously strive to make breakthroughs in the market in the form of new and effective drugs.


TBRC’s Biosimilars Market Report Covers:

Major Market Players: Amgen, Pfizer, Novartis AG, Viatris, Samsung Bioepis Co., Ltd.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)


The Biosimilars Market Report 2022 is one of a series of new reports from The Business Research Company that provides biosimilars market overviews, analyzes and forecasts market size, share, biosimilars market players, biosimilars market segments and geographies, leading competitor revenues, profiles and market shares.


TBRC’s biosimilars market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.


Here Is A List Of Similar Reports From The Business Research Company:

Biosimilar Monoclonal Antibodies Global Market Report 2022

Rituximab Biosimilars Global Market Report 2022

Biosimilar Lymphocyte Modulator Global Market Report 2022


 Interested To Know More About The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.


Read More About Us At


Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Follow us on Facebook:
Follow us on LinkedIn:
Follow us on Twitter:
Check out our Global Market Model:

Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *